Drug Type Small molecule drug |
Synonyms Mefruside (JP17/USAN/INN), Baycaron + [1] |
Target |
Action inhibitors |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (20 Jan 1975), |
Regulation- |
Molecular FormulaC13H19ClN2O5S2 |
InChIKeySMNOERSLNYGGOU-UHFFFAOYSA-N |
CAS Registry7195-27-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Essential Hypertension | Japan | 27 Nov 1976 | |
Hypertension, Renal | Japan | 27 Nov 1976 | |
Edema | Japan | 20 Jan 1975 |